Ionis Pharmaceuticals Stock Forecast for 2023 - 2025 - 2030

Updated on 02/01/2023

Stock Rating
9
Price Target
$50.00
Consensus
Outperform
Upside
25.41%
Analysts
6
Stock Rating
9
Upside
25.41%
Analysts
6
Price Target
$50.00

Ionis Pharmaceuticals Stock Forecast and Price Target

The average price target of $50.00 for Ionis Pharmaceuticals's stock set by six distinguished analysts in recent weeks would represent a potential upside of approximately 25.41% from the last closing price in January, 2023 if reached by the end of the year. This potential increase is based on a high estimate of $92.00 and a low estimate of $26.00. If you are interested in IONS stock, it is important to also consider its competitors.

$50.00

25.41% Upside

Outperform
Outperform

Ionis Pharmaceuticals Fair Value Forecast for 2023 - 2025 - 2030

Ionis Pharmaceuticals's Price has decreased by 62.56% In the last two years, from $32.85 to $12.30. In the next year, analysts predict that Fair Value will jump to $30.35 – up 146.78% from the current level. Looking ahead to nine years, experts forecast that Fair Value will grow by 1276.11%.

2022 Fair Value Forecast
$30.35
2023 Fair Value Forecast
$83.33
2024 Fair Value Forecast
$9.52
2025 Fair Value Forecast
$30.22
2026 Fair Value Forecast
$95.02
2027 Fair Value Forecast
$297.31
2028 Fair Value Forecast
$94.41
2029 Fair Value Forecast
$119.17
2030 Fair Value Forecast
$169.26
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
PFE Stock Forecast Pfizer Inc Outperform 3
$44.16 $53.97 19.23%
AMGN Stock Forecast Amgen Inc Hold 7
$271.73 $268.00 2.31%
SAN Stock Forecast Sanofi Outperform 10
91.12€ 108.44€ 20.72%
MRNA Stock Forecast Moderna Outperform 11
$176.06 $0.00 21.27%
4568 Stock Forecast Daiichi Sankyo Company Outperform 18
¥4.07k ¥0.00 35.30%

Ionis Pharmaceuticals Revenue Forecast for 2023 - 2025 - 2030

Ionis Pharmaceuticals's Revenue has decreased by 27.81% In the last two years, from $1.12B to $810.46M. In the next year, analysts predict that Revenue will jump to $902.04M – up 11.30% from the current level. Looking ahead to nine years, experts forecast that Revenue will grow by 10.87%.

2022 Rev Forecast
$0.90B
2023 Rev Forecast
$1.00B
2024 Rev Forecast
$0.90B
2025 Rev Forecast
$0.88B
2026 Rev Forecast
$0.89B
2027 Rev Forecast
$0.93B
2028 Rev Forecast
$0.92B
2029 Rev Forecast
$0.90B
2030 Rev Forecast
$0.90B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
ALNY Stock Forecast Alnylam Pharmaceuticals Outperform 7
$226.40 $244.18 10.87%
SGEN Stock Forecast Seagen Outperform 6
$139.48 $167.40 11.13%
BMRN Stock Forecast BioMarin Pharmaceutical Outperform 10
$115.35 $115.45 4.03%

Ionis Pharmaceuticals Dividend per Share Forecast for 2023 - 2025 - 2030

Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
INCY Stock Forecast Incyte Outperform 9
$85.14 $88.18 1.01%
SRPT Stock Forecast Sarepta Therapeutics Outperform 6
$124.97 $139.65 21.63%
JAZZ Stock Forecast Jazz Pharmaceuticals Outperform 14
$158.79 $0.00 25.95%

Ionis Pharmaceuticals Free Cash Flow Forecast for 2023 - 2025 - 2030

In the last two years, Ionis Pharmaceuticals's Free Cash Flow has decreased by 94.01%, from $314.72M to $18.84M. In the coming year, analysts are expecting an increase in Free Cash Flow, predicting it will reach $2.57B – an increase of 13526.97%. Over the next nine years, experts anticipate that Free Cash Flow growth for Ionis Pharmaceuticals will be 411619284.33%.

2022 FCF Forecast
$2.57B
2023 FCF Forecast
$349.82B
2024 FCF Forecast
$6.47B
2025 FCF Forecast
$116.64B
2026 FCF Forecast
$2104.03B
2027 FCF Forecast
$37988.26B
2028 FCF Forecast
$2105.82B
2029 FCF Forecast
$12740.54B
2030 FCF Forecast
$77549.09B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
EXEL Stock Forecast Exelixis Outperform 16
$17.62 $26.06 41.88%
4516 Stock Forecast Nippon Shinyaku Outperform 18
¥7.07k ¥0.00 55.59%
DCPH Stock Forecast Deciphera Pharmaceuticals Hold 6
$17.01 $0.00 -41.21%

Ionis Pharmaceuticals Net Income Forecast for 2023 - 2025 - 2030

In the last two years, Ionis Pharmaceuticals has seen a decline in its Net Income, from $278.14M to $-28.60M – a 110.28% decrease. In the next year, analysts believe that Net Income will reach $-321.21M – an increase of 1023.11%. For the next nine years, the forecast is forNet Income to grow by 34621.13%.

2022 NI Forecast
$-321209460.00
2023 NI Forecast
$-1953885024.23
2024 NI Forecast
$-10281994292.53
2025 NI Forecast
$-1519678756.44
2026 NI Forecast
$-3606856216.48
2027 NI Forecast
$-8869499893.41
2028 NI Forecast
$-22451365080.19
2029 NI Forecast
$-9153421543.20
2030 NI Forecast
$-9930241918.16
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
STOK Stock Forecast Stoke Therapeutics Buy 4
$9.95 $61.44 422.61%
DYN Stock Forecast Dyne Therapeutics Buy 5
$14.61 $0.00 57.43%
ABUS Stock Forecast Arbutus Biopharma Outperform 9
$3.01 $8.29 156.81%

Ionis Pharmaceuticals EBITDA Forecast for 2023 - 2025 - 2030

In the last two years, Ionis Pharmaceuticals's EBITDA has fallen from $382.56M to $14.26M – a 96.27% decrease. According to 0 prominent analysts, Ionis Pharmaceuticals's EBITDA will fall by 526.17% in the next year, reaching $-60.77M. By 2030, professionals believe that Ionis Pharmaceuticals's EBITDA will decrease by 679.42%, reaching $-82.63M – a concerning trend for the company.

2022 EBITDA Forecast
$-60771366.67
2023 EBITDA Forecast
$0.03B
2024 EBITDA Forecast
$-94547165.50
2025 EBITDA Forecast
$-87326913.62
2026 EBITDA Forecast
$-47127424.39
2027 EBITDA Forecast
$-83091932.85
2028 EBITDA Forecast
$-97020910.53
2029 EBITDA Forecast
$-105966238.48
2030 EBITDA Forecast
$-82625408.35

Ionis Pharmaceuticals EBIT Forecast for 2023 - 2025 - 2030

Ionis Pharmaceuticals's EBIT has decreased In the last two years, from $368.11M to $-3.58M – a 100.97% drop. In the next year, analysts are expecting an increase in EBIT, predicting it will reach $-100.36M – an increase of 2703.34%. The Ionis Pharmaceuticals forecast is for EBIT to reach $-76.25B or grow by 2129808.58%.

2022 EBIT Forecast
$-100359691.33
2023 EBIT Forecast
$-1484620913.89
2024 EBIT Forecast
$-19725811671.36
2025 EBIT Forecast
$-1174343321.50
2026 EBIT Forecast
$-6631203578.30
2027 EBIT Forecast
$-37686677216.32
2028 EBIT Forecast
$-215447196310.28
2029 EBIT Forecast
$-37918706550.61
2030 EBIT Forecast
$-76250727002.62

Ionis Pharmaceuticals EPS Price Prediction Forecast for 2023 - 2025 - 2030

Ionis Pharmaceuticals's EPS has decreased by 62.56% In the last two years, from $2.19 to $0.82. In the next year, analysts predict that EPS will jump to $2.02 – up 146.78% from the current level. Looking ahead to nine years, experts forecast that EPS will grow by 1276.11%.

2022 EPS Forecast
$2.02
2023 EPS Forecast
$5.56
2024 EPS Forecast
$0.63
2025 EPS Forecast
$2.01
2026 EPS Forecast
$6.33
2027 EPS Forecast
$19.82
2028 EPS Forecast
$6.29
2029 EPS Forecast
$7.94
2030 EPS Forecast
$11.28